Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biovaxys Technology Corp (BIOV.CN)

Biovaxys Technology Corp (BIOV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 13,581
  • Shares Outstanding, K 246,926
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,687 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.59
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings $-0.01 on 09/27/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0525 +4.76%
on 12/10/24
0.0700 -21.43%
on 12/05/24
-0.0100 (-15.38%)
since 11/12/24
3-Month
0.0450 +22.22%
on 10/18/24
0.0800 -31.25%
on 11/05/24
-0.0050 (-8.33%)
since 09/12/24
52-Week
0.0100 +450.00%
on 12/14/23
0.1000 -45.00%
on 02/28/24
+0.0400 (+266.67%)
since 12/12/23

Most Recent Stories

More News
BIOVAXYS ANNOUNCES REPRICING OF PRIVATE PLACEMENT OFFERING

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces that it has reduced the price per unit of the Company...

BIOV.CN : 0.0550 (unch)
Stocks in play: BioVaxys Technology Corp

Presented a new study today at the Personalized Cancer Vaccine Summit (formerly known as the mRNA Cancer ...

BIOV.CN : 0.0550 (unch)
BioVaxys Shares New Data on its DPX™ Immune Educating Platform at Personalized Cancer Vaccine Summit

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the Company") presented a new study today at the Personalized Cancer...

BVAXF : 0.0422 (-2.99%)
BIOV.CN : 0.0550 (unch)
Can Emerging Agritech and Biotech Solutions Meet the World’s Food Security Demands?

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – Reception to recent US election results has been mixed within the agriculture sector, with enthusiasm from some and...

CALM : 105.89 (+0.12%)
BVAXF : 0.0422 (-2.99%)
CTVA : 59.30 (-0.80%)
ELAN : 12.59 (+0.48%)
BIOV.CN : 0.0550 (unch)
ZTS : 178.84 (+0.94%)
Stocks in play: BioVaxys Technology Corp

Along with SpayVac for Wildlife, Inc. are pleased to jointly announce that SpayVac for Wildlife, Inc.'s ...

BIOV.CN : 0.0550 (unch)
BIOVAXYS PARTNER SPAYVAC FOR WILDLIFE, INC., SCALES-UP VACCINE PRODUCTION CAPACITY

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to jointly announce that...

BVAXF : 0.0422 (-2.99%)
BIOV.CN : 0.0550 (unch)
BIOVAXYS ANNOUNCES PRIVATE PLACEMENT OFFERING

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce that it intends to complete a non-brokered...

BIOV.CN : 0.0550 (unch)
Stocks in play: BioVaxys Technology Corp

Announces it has been invited to and joined The Rapid Response Partnership Vehicle (RRPV), a consortium ...

BIOV.CN : 0.0550 (unch)
BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that it has been invited to and...

BVAXF : 0.0422 (-2.99%)
BIOV.CN : 0.0550 (unch)
Stocks in play: BioVaxys Technology Corp

Announces studies showing that its novel immune educating delivery platform, DPX™, recruits and activates ...

BIOV.CN : 0.0550 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioVaxys Technology Corp is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix 'neoantigen' tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization,...

See More

Key Turning Points

3rd Resistance Point 0.0550
2nd Resistance Point 0.0550
1st Resistance Point 0.0550
Last Price 0.0550
1st Support Level 0.0550
2nd Support Level 0.0550
3rd Support Level 0.0550

See More

52-Week High 0.1000
Fibonacci 61.8% 0.0656
Fibonacci 50% 0.0550
Last Price 0.0550
Fibonacci 38.2% 0.0444
52-Week Low 0.0100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar